※ PTMD 2.0 database Online Browse Options
Browse result for Uterus disease
• There are 7051 unique proteins containing the PTMs that associate with disease.
An endometrial carcinoma that derives_from epithelial cells of glandular origin. Reference DiseaseOntology: Endometrial adenocarcinoma | Endometrial cancer (17) A uterine cancer that is located_in tissues lining the uterus. Reference DiseaseOntology: Endometrial cancer | Endometrial cancer is a cancer that arises from the endometrium (the lining of the uterus or womb). It is the result of the abnormal growth of cells that have the ability to invade or spread to other parts of the body. The first sign is most often vaginal bleeding not associated with a menstrual period. Other symptoms include pain with urination, pain during sexual intercourse, or pelvic pain. Endometrial cancer occurs most commonly after menopause.
Approximately 40% of cases are related to obesity. Endometrial cancer is also associated with excessive estrogen exposure, high blood pressure and diabetes. Whereas taking estrogen alone increases the risk of endometrial cancer, taking both estrogen and a progestogen in combination, as in most birth control pills, decreases the risk. Between two and five percent of cases are related to genes inherited from the parents. Endometrial cancer is sometimes called "uterine cancer", although it is distinct from other forms of cancer of the uterus such as cervical cancer, uterine sarcoma, and trophoblastic disease. The most frequent type of endometrial cancer is endometrioid carcinoma, which accounts for more than 80% of cases. Endometrial cancer is commonly diagnosed by endometrial biopsy or by taking samples during a procedure known as dilation and curettage. A pap smear is not typically sufficient to show endometrial cancer. Regular screening in those at normal risk is not called for.
The leading treatment option for endometrial cancer is abdominal hysterectomy (the total removal by surgery of the uterus), together with removal of the Fallopian tubes and ovaries on both sides, called a bilateral salpingo-oophorectomy. In more advanced cases, radiation therapy, chemotherapy or hormone therapy may also be recommended. If the disease is diagnosed at an early stage, the outcome is favorable, and the overall five-year survival rate in the United States is greater than 80%.
In 2012, endometrial cancers newly occurred in 320,000 women and caused 76,000 deaths. This makes it the third most common cause of death in cancers which only affect women, behind ovarian and cervical cancer. It is more common in the developed world and is the most common cancer of the female reproductive tract in developed countries. Rates of endometrial cancer have risen in a number of countries between the 1980s and 2010. This is believed to be due to the increasing number of elderly people and increasing rates of obesity. Reference Wiki: Endometrial cancer/carcinoma |
Endometriosis (1) A female reproductive system disease characterized by the growth of endometrial tissue outside the uterine body. Reference DiseaseOntology: Endometriosis | PTEN phosphatase, a product of PTEN tumor suppressor gene, exists in cells in phosphorylated and unphosphorylated form and has a central role in regulation of PI3K/Akt signalling which is involved in non-genomic action of estradiol. Reference Pubmed: Fibromyomatous uteri | Polyhydramnios (1) Polyhydramnios is a medical condition describing an excess of amniotic fluid in the amniotic sac. It is seen in about 1% of pregnancies. It is typically diagnosed when the amniotic fluid index (AFI) is greater than 24 cm.
There are two clinical varieties of polyhydramnios: chronic polyhydramnios where excess amniotic fluid accumulates gradually, and acute polyhydramnios where excess amniotic fluid collects rapidly.
The opposite to polyhydramnios is oligohydramnios, not enough amniotic fluid.
Reference Wiki: Polyhydramnios |
Uterine cancer (1494) A female reproductive organ cancer that is located_in the uterus. Reference DiseaseOntology: Uterine cancer | Uterine carcinosarcoma (575) A uterine body mixed cancer that has_material_basis_in both endometrial carcinoma and sarcoma. Reference DiseaseOntology: Uterine carcinosarcoma | A uterine corpus cancer that is derives_from the inner lining of the uterus. Reference DiseaseOntology: Uterine corpus endometrial carcinoma |
A uterine corpus cancer that is derives_from the inner lining of the uterus. Reference DiseaseOntology: uterine corpus endometrioid carcinoma | Placental insufficiency or utero-placental insufficiency is the failure of the placenta to deliver sufficient nutrients to the fetus during pregnancy, and is often a result of insufficient blood flow to the placenta. The term is also sometimes used to designate late decelerations of fetal heart rate as measured by cardiotocography or an NST, even if there is no other evidence of reduced blood flow to the placenta, normal uterine blood flow rate being 600mL/min. Reference Wiki: Uteroplacental insufficiency | Uterus adenocarcinoma (591) An endometrial carcinoma that derives_from epithelial cells of glandular origin. Reference DiseaseOntology: Uterus adenocarcinoma |
